Based to the CPTAC dataset, CDKN1B protein levels were reduced in tumor tissues from breast cancer and clear cell RCC compared to controls (Fig. 1C), but they did not statistically differ from colon cancer, lung adenocarcinoma, ovarian cancer, and UCEC, respectively. This evidence concerns the gene CDKN1B and ovarian carcinoma.